Skip to main content
LLY
NYSE Life Sciences

Lilly Signs Up-to-$5.9B Oncology Licensing Deal With Stipple Bio

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1,416.225
Mkt Cap
$1.332T
52W Low
$850.51
52W High
$1,475.25
52W Position info
67% above low
Off High info
4.0% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

LLY sits 67% above its 52-week low of $850.51 on light trading volume (0.3× avg).

Summary

Lilly signed an exclusive worldwide licensing deal with private Cambridge, Massachusetts biotech Stipple Bio to discover and commercialize tumor-targeting cancer drugs. Lilly pays an upfront fee and makes an equity investment; Stipple can collect up to $5.9B in milestones plus tiered sales royalties. The headline number is a ceiling, not cash out the door — the upfront is undisclosed and the real cost depends on programs reaching the clinic and market. It is a pipeline bet, not a revenue event: Lilly's Q3 revenue was $24.4B, so $5.9B in contingent milestones is modest relative to the base business but meaningful for the oncology franchise. This is Lilly's 14th deal this year, following the up-to-$1.5B Calytrix Bio acquisition for rare blood disorders, continuing an aggressive bolt-on strategy that has already produced $4.2B of acquired IPR&D charges in Q3.

At the time of this announcement, LLY was trading at $1,416.23 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.3T. The 52-week trading range was $850.51 to $1,475.25. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,417.32 info
Change: -$38.04 (-3%) info
Market Cap: $1.334T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,417.32 info
Change: -$35.38 (-2%) info
Market Cap: $1.334T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,417.32 info
Change: -$30.53 (-2%) info
Market Cap: $1.334T info
LLY
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,411.12
Real-time Price: $1,417.32 info
Change: +$6.20 (+0.44%) info
Market Cap: $1.334T info
LLY
Nov 09, 2026, 10:23 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1,394.15
Real-time Price: $1,417.32 info
Change: +$23.17 (+2%) info
Market Cap: $1.334T info